Pharmacovigilance challenges in Biosimilars


Same proportion pharmacovigilance for biosimilars has comparatively more different from other products. Biosimilars 2019 session mainly look that have already been announced to incorporate enhanced tracking and follow-up of post marketing surveillance issues, and on FDA initiative planned different changes in AERS, pilots of latest developed post market strategies of drug-monitoring and ADR related problems. the rules of biosimilars for pharmacovigilance and pharma epidemiology are the points that shall be laid emphasis within the session In USA average annual income mostly spend on biologics comparing to generic drugs for example:16% on biologics and three on other drugs.


  • Manufacturing methods
  • Product names
  • Generics and brand name products
  • Postapproval surveillance for immunogenicity
  • Evolving guidelines

Related Conference of Pharmacovigilance challenges in Biosimilars

April 03-04, 2023

16th European Biosimilars Congress

Barcelona, Spain
April 25-26, 2023

4th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 07-08, 2023

Advanced-Materials 2023

Valencia, Spain
July 06-07, 2023

5th World Congress on Drug Discovery and Drug Design

Vancouver, Canada
July 25-26, 2023

36th World Congress on Pharmacology

Amsterdam, Netherlands
August 11-12, 2023

38th World Congress on Pharmacology and Therapeutics

Singapore City, Singapore
September 06-07, 2023

16th World Drug Delivery Summit

London, UK
September 14-15, 2023

10th international conference on Physiotherapy

Bangkok, Thailand
September 27-28, 2023

3rd World Congress on Rare Diseases & Orphan Drugs

Amsterdam, Netherlands
September 27-28, 2023

8th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
October 09-10, 2023

20th International Conference on Pharmaceutical Chemistry

Barcelona, Spain
October 12-13, 2023

26th World Congress on Nursing, Pharmacology and Healthcare

Budapest, Hungary
November 09-10, 2023

11th International Conference on Clinical Trials

London, UK
November 10-11, 2023

3rd World Biosimilars & Biologics Congress

Berlin, Germany
November 27-28, 2023

19th World Congress on Drug Formulation & Drug Delivery

Bangkok, Thailand
December 05-06, 2023

2nd World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Pharmacovigilance challenges in Biosimilars Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in